← Back to headlines
Amlitelimab Setback Not Enough to Sink Sanofi's Multi-Billion Dollar Engine
Despite a recent setback with Amlitelimab, analysts suggest that the incident is unlikely to significantly impact Sanofi's multi-billion dollar pharmaceutical engine.
10 Aug, 23:29 — 10 Aug, 23:29
Sources
Showing 1 of 1 sources
